UMIN-CTR Clinical Trial

Recruitment status Completed
Unique ID issued by UMIN UMIN000012640
Receipt No. R000014771
Official scientific title of the study Observational study to assess dose-up efficacy of anticholinergic agent on nocturia in overactive bladder patients
Date of disclosure of the study information 2013/12/20
Last modified on 2016/12/14 (Ver. 6)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Official scientific title of the study Observational study to assess dose-up efficacy of anticholinergic agent on nocturia in overactive bladder patients
Title of the study (Brief title) Observational study to assess dose-up efficacy of anticholinergic agent on nocturia in overactive bladder patients(Dose Flex Study)
Region
Japan

Condition
Condition Overactive bladder
Classification by specialty
Urology
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 To observe the change of nocturia symptom in OAB patients (IPSS Q7(nocturia score >=3))
Basic objectives2 Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes Change in IPSS Q7 (nocturia score) as change in nocturnal voids
Key secondary outcomes

Base
Study type Observational

Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit

Not applicable
Gender Male and Female
Key inclusion criteria 1)Patients who are regarded as overactive bladder at the start of dosing imidafenacin
2)Patients who have the follow criteria even after administering imidafenacin for more than 4 weeks
IPSS Q7(nocturia score) >=3
3)Aged >=20 years
Key exclusion criteria 1)Patients with contraindications for imidafenacin
2)Patients who have current condition of severe difficulty of urination
3)Patients who have history of urinary retention
4)Patients with serious kidney dysfunction
5)Residual urine volume > 50 mL
6)Patients with cancer in bladder, cystoliths, urinary tract infection, recurrent urinary tract infection or interstitial cystitis
7)Patients with polyuria
8)Patients who have administered prohibited substances or done prohibited therapy in the 4 weeks prior to the start of study (excepting operations on urinary and sexual organs)
9)Patients who have been operated on the urinary or sexual organs in the 6 months prior to the start of study
10)Patients with unstable lower urinary tract symptoms
11)Any other patients who are regarded as unsuitable for this study by the investigator
Target sample size 100

Research contact person
Name of lead principal investigator Yasuyuki Suzuki
Organization Tokyo Metropolitan Rehabilitation Hospital
Division name Department of Medical Care
Address 2-14-1 Tutumidori Sumida-Ward, Tokyo
TEL 03-3616-8600
Email ysuro@jikei.ac.jp

Public contact
Name of contact person Yasuyuki Suzuki
Organization Tokyo Metropolitan Rehabilitation Hospital
Division name Department of Medical Care
Address 2-14-1 Tutumidori Sumida-Ward, Tokyo
TEL 03-3616-8600
Homepage URL
Email ysuro@jikei.ac.jp

Sponsor
Institute Clinical Research Support Center Kyushu
Institute
Department

Funding Source
Organization Kyorin Pharmaseutical Co.,Ltd.
Organization
Division
Category of Funding Organization Profit organization
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2013 Year 12 Month 20 Day

Progress
Recruitment status Completed
Date of protocol fixation
2013 Year 12 Month 03 Day
Anticipated trial start date
2013 Year 12 Month 24 Day
Last follow-up date
2015 Year 05 Month 30 Day
Date of closure to data entry
Date trial data considered complete
2015 Year 07 Month 31 Day
Date analysis concluded
2015 Year 08 Month 31 Day

Related information
URL releasing protocol
Publication of results Unpublished
URL releasing results
Results
Other related information Prospective observational study

Management information
Registered date
2013 Year 12 Month 20 Day
Last modified on
2016 Year 12 Month 14 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000014771